The price of this share is at 14,70$, Amryt Pharma Holdings Ltd is a company created in United Kingdom dedicated to Biotechnology: Pharmaceutical Preparations with its highest number of sales in Europe. Its Executives are Joseph A. Wiley (Chief Executive Officer & Executive Director), Mark Sumeray (Chief Medical Officer), Rory Peter Nealon (Secretary, Chief Operating & Financial Officer) and its address is 196 HIGH ROAD DEPT 920A, WOOD GREEN, LONDON, N22 8HH, United Kingdom.
Yesterday this stock ended the day with a value of desconocido$.
With an intraday difference of 14,70$ moving between 14,63$ and 14,76$, it is a notable difference that allows quick purchases and sales.
Their latest annual data shows an income of desconocido.
The opening price that appears as last recorded is desconocido.
If we think of formulas to know when to buy or sell a stock, a value that appears in them always comes to mind, which is the range between the lowest and the highest price that the stock has obtained, for example, here it has been between 0,00$ and 0,00$.
EPS is the net profit that the company has obtained, after paying taxes, divided by the number of total shares it has in circulation. This value is higher the better the company has done, although with some nuances since it can increase if the number of shares for sale decreases, or it can decrease if things that have happened in just a few months are charged annually. For this action the BPA is [BPA].
Buscar
